Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Urologic Oncology
|
January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
European Urology Focus
|
June 5, 2025
Intrarenal Fluid Temperature During Laser Lithotripsy: A Mini Review by the European Association of Urology Endourology Section
Felipe Pauchard, Mariela Corrales, Davide Perri, et al.
Cancer Treatment Reviews
|
August 8, 2022
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis
Giuseppe Fallara, Daniele Robesti, Luigi Nocera, et al.
Frontiers in Oncology
|
September 22, 2022
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation
Luigi Nocera, Giuseppe Fallara, Daniele Raggi, et al.
Critical Reviews in Oncology/Hematology
|
August 28, 2022
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
BJU International
|
July 9, 2023
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials
Daniele Robesti, Luigi Nocera, Federico Belladelli, et al.
European Urology
|
March 17, 2018
The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy
Giorgio Gandaglia, Carlo Andrea Bravi, Paolo Dell'Oglio, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2025
Trimodal treatment vs radical cystectomy for muscle-invasive bladder cancer: The neglected impact of informative censoring. A systematic review and meta-analysis
Daniele Robesti, Filippo Micheli, Shesh N Rai, et al.
BJU International
|
March 7, 2026
Ureteroscope-sheath size mismatch affects intrarenal pressure during suction-assisted flexible ureteroscopy: a human ex vivo study
Andrea Folcia, Pietro Scilipoti, Daniele Robesti, et al.
BJU International
|
November 19, 2025
In vitro comparison of stone retropulsion between the new holmium:yttrium aluminium garnet laser generator with a very low peak power pulse modulation mode (Magneto technology) and the thulium fibre laser
Andrea Folcia, Davide Perri, Luca Villa, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Urologic Oncology
|
January 9, 2025
Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
European Urology Focus
|
June 5, 2025
Intrarenal Fluid Temperature During Laser Lithotripsy: A Mini Review by the European Association of Urology Endourology Section
Felipe Pauchard, Mariela Corrales, Davide Perri, et al.
Cancer Treatment Reviews
|
August 8, 2022
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis
Giuseppe Fallara, Daniele Robesti, Luigi Nocera, et al.
Frontiers in Oncology
|
September 22, 2022
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation
Luigi Nocera, Giuseppe Fallara, Daniele Raggi, et al.
Critical Reviews in Oncology/Hematology
|
August 28, 2022
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis
Giuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
BJU International
|
July 9, 2023
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials
Daniele Robesti, Luigi Nocera, Federico Belladelli, et al.
European Urology
|
March 17, 2018
The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy
Giorgio Gandaglia, Carlo Andrea Bravi, Paolo Dell'Oglio, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2025
Trimodal treatment vs radical cystectomy for muscle-invasive bladder cancer: The neglected impact of informative censoring. A systematic review and meta-analysis
Daniele Robesti, Filippo Micheli, Shesh N Rai, et al.
BJU International
|
March 7, 2026
Ureteroscope-sheath size mismatch affects intrarenal pressure during suction-assisted flexible ureteroscopy: a human ex vivo study
Andrea Folcia, Pietro Scilipoti, Daniele Robesti, et al.
BJU International
|
November 19, 2025
In vitro comparison of stone retropulsion between the new holmium:yttrium aluminium garnet laser generator with a very low peak power pulse modulation mode (Magneto technology) and the thulium fibre laser
Andrea Folcia, Davide Perri, Luca Villa, et al.
Page
of 6